SOD1 and in situ carcinoma: Furthermore, the normalization of CIS-induced SOD-1 downregulation produced by both treatments, given alone and combined, in both sexes also suggests the participation of this antioxidant enzyme in the antiallodynic actions and the recuperation of muscle loss produced by these treatments.